Buprenorphine and Dysphagia aggravated - a phase IV clinical study of FDA data
Dysphagia aggravated is found among people who take Buprenorphine, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Buprenorphine and have Dysphagia aggravated. It is created by eHealthMe based on reports of 8,882 people who have side effects when taking Buprenorphine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
8,882 people reported to have side effects when taking Buprenorphine.
Among them, 65 people (0.73%) have Dysphagia aggravated.
What is Buprenorphine?
Buprenorphine has active ingredients of buprenorphine. eHealthMe is studying from 8,984 Buprenorphine users for its effectiveness, alternative drugs and more.
What is Dysphagia aggravated?
Dysphagia aggravated (serious condition in which swallowing is difficult or painful) is found to be associated with 1,365 drugs and 446 conditions by eHealthMe.
Number of Buprenorphine and Dysphagia aggravated reports submitted per year:
Time on Buprenorphine when people have Dysphagia aggravated *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Dysphagia aggravated when taking Buprenorphine *:
- female: 43.1 %
- male: 56.9 %
Age of people who have Dysphagia aggravated when taking Buprenorphine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 2.56 %
- 40-49: 0.0 %
- 50-59: 5.13 %
- 60+: 92.31 %
Common drugs people take besides Buprenorphine *:
- Paracetamol: 32 people, 49.23%
- Oxycodone: 15 people, 23.08%
- Pantoprazole: 14 people, 21.54%
- Zopiclone: 12 people, 18.46%
- Morphine: 10 people, 15.38%
- Metformin: 7 people, 10.77%
- Acetylsalicylic Acid: 5 people, 7.69%
- Xanax: 4 people, 6.15%
- Jentadueto: 3 people, 4.62%
- Linagliptin: 3 people, 4.62%
Common side effects people have besides Dysphagia aggravated *:
- Muscle Rigidity (muscle stiffness): 34 people, 52.31%
- Weakness: 31 people, 47.69%
- Fall: 30 people, 46.15%
- Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 23 people, 35.38%
- Delirium (wild excitement): 22 people, 33.85%
- Movement - Uncontrolled Or Slow: 22 people, 33.85%
- Mastication Disorder (disease of chewing food): 22 people, 33.85%
- Tardive Dyskinesia (a disorder that involves involuntary movements): 22 people, 33.85%
- Aptyalism (deficiency or absence of saliva): 22 people, 33.85%
- Sarcopenia (loss of muscle mass and strength): 22 people, 33.85%
Common conditions people have *:
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 18.46%
- Dementia With Lewy Bodies (progressive degenerative disease or syndrome of the brain): 9 people, 13.85%
- Muscle Rigidity (muscle stiffness): 7 people, 10.77%
- Pain: 7 people, 10.77%
- Confusional State: 6 people, 9.23%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 7.69%
- Neuralgia (pain in one or more nerves): 3 people, 4.62%
- Depression: 3 people, 4.62%
- High Blood Pressure: 2 people, 3.08%
- Diabetes: 2 people, 3.08%
* Approximation only. Some reports may have incomplete information.
Do you take Buprenorphine and have Dysphagia aggravated?Check whether Dysphagia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Dysphagia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of buprenorphine:
Alternative drugs to, pros and cons of Buprenorphine:
- Buprenorphine (8,984 reports)
Common Buprenorphine side effects:
- Drug abuse: 948 reports
- Drug abuse and dependence: 774 reports
- Drug ineffective: 755 reports
- Death: 508 reports
- Pain: 493 reports
Browse all side effects of Buprenorphine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Dysphagia aggravated treatments and more:
- Dysphagia aggravated (9 reports)
COVID vaccines that are related to Dysphagia aggravated:
- Dysphagia aggravated in Moderna COVID Vaccine
- Dysphagia aggravated in Pfizer BioNTech Covid Vaccine
- Dysphagia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Dysphagia aggravated:
- Aspirin: 4,818 reports
- Prednisone: 4,430 reports
- Omeprazole: 3,202 reports
- Lisinopril: 2,813 reports
- Nexium: 2,643 reports
- Synthroid: 2,587 reports
- Fosamax: 2,524 reports
- Gabapentin: 2,402 reports
- Lipitor: 2,354 reports
- Amlodipine: 2,344 reports
All the drugs that are associated with Dysphagia aggravated:
- Dysphagia aggravated (1,365 drugs)
Common conditions associated with Dysphagia aggravated:
- High blood pressure: 4,427 reports
- Multiple sclerosis: 3,600 reports
- Pain: 3,308 reports
- Depression: 2,699 reports
- Parkinson's disease: 2,677 reports
- Osteoporosis: 2,629 reports
- Rheumatoid arthritis: 2,416 reports
- High blood cholesterol: 2,152 reports
All the conditions that are associated with Dysphagia aggravated:
- Dysphagia aggravated (446 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on buprenorphine (the active ingredients of Buprenorphine) and Buprenorphine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Entecavir and Bradycardia - 25 seconds ago
- Septocaine and Rashes - 26 seconds ago
- Astelin and Pleurisy - 26 seconds ago
- Automatic Bladder and Urinary Incontinence - 28 seconds ago
- Ileitis Aggravated and Complications Of Maternal Exposure To Therapeutic Drugs - 41 seconds ago
- Acne and Transverse Sinus Thrombosis - 55 seconds ago
- Chronic Myeloid Leukaemia and Nitrite Urine Present - 56 seconds ago
- Apriso and Depression - 57 seconds ago
- Ceftriaxone Sodium and Dermatitis Exfoliative Aggravated - a minute ago
- Enalapril Maleate and Superior Vena Caval Occlusion - a minute ago